Pain Therapeutics, Inc. (NASDAQ:PTIE)

CAPS Rating: 3 out of 5

A biopharmaceutical company that develops novel drugs for pain management and oncology.

Recs

0
Player Avatar tharlow (31.04) Submitted: 10/27/2007 12:31:05 AM : Outperform Start Price: $7.75 PTIE Score: -41.29

This could be massive.

Report this Post Reply

Featured Broker Partners


Advertisement